🎉 M&A multiples are live!
Check it out!

Abbott Laboratories (Pakistan) Valuation Multiples

Discover revenue and EBITDA valuation multiples for Abbott Laboratories (Pakistan) and other public comps.

See Abbott Laboratories (Pakistan) Valuation Multiples

Abbott Laboratories (Pakistan) Overview

About Abbott Laboratories (Pakistan)

Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.


Founded

1948

HQ

Pakistan
Employees

1.4K+

Website

pk.abbott

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$419M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Abbott Laboratories (Pakistan) Financials

Abbott Laboratories (Pakistan) has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Abbott Laboratories (Pakistan) achieved revenue of $199M and an EBITDA of $15.1M.

Abbott Laboratories (Pakistan) expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Abbott Laboratories (Pakistan) valuation multiples based on analyst estimates

Abbott Laboratories (Pakistan) P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $177M $199M n/a n/a XXX
Gross Profit $57.8M $52.2M $42.6M XXX XXX
Gross Margin 33% 26% NaN% XXX XXX
EBITDA $27.4M $15.1M n/a n/a XXX
EBITDA Margin 15% 8% NaN% NaN% XXX
Net Profit $21.4M $10.8M $0.9M XXX XXX
Net Margin 12% 5% NaN% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Abbott Laboratories (Pakistan) Stock Performance

As of February 14, 2025, Abbott Laboratories (Pakistan)'s stock price is PKR 1230 (or $4).

Abbott Laboratories (Pakistan) has current market cap of PKR 120B (or $433M), and EV of PKR 117B (or $419M).

See Abbott Laboratories (Pakistan) trading valuation data

Abbott Laboratories (Pakistan) Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$419M $433M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Abbott Laboratories (Pakistan) Valuation Multiples

As of February 14, 2025, Abbott Laboratories (Pakistan) has market cap of $433M and EV of $419M.

Abbott Laboratories (Pakistan)'s trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Abbott Laboratories (Pakistan)'s 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Abbott Laboratories (Pakistan) and 10K+ public comps

Abbott Laboratories (Pakistan) Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $419M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Abbott Laboratories (Pakistan) Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Abbott Laboratories (Pakistan) Valuation Multiples

Abbott Laboratories (Pakistan)'s NTM/LTM revenue growth is n/a

Abbott Laboratories (Pakistan)'s revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $23K for the same period.

Over next 12 months, Abbott Laboratories (Pakistan)'s ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Abbott Laboratories (Pakistan)'s 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Abbott Laboratories (Pakistan) and other 10K+ public comps

Abbott Laboratories (Pakistan) Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth n/a XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $23K XXX XXX XXX XXX
S&M Expenses to Revenue 8% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 0% XXX XXX XXX XXX
Opex to Revenue 17% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Abbott Laboratories (Pakistan) Public Comps

See valuation multiples for Abbott Laboratories (Pakistan) public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Abbott Laboratories (Pakistan) M&A and Investment Activity

Abbott Laboratories (Pakistan) acquired  XXX companies to date.

Last acquisition by Abbott Laboratories (Pakistan) was  XXXXXXXX, XXXXX XXXXX XXXXXX . Abbott Laboratories (Pakistan) acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Abbott Laboratories (Pakistan)

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Abbott Laboratories (Pakistan)

When was Abbott Laboratories (Pakistan) founded? Abbott Laboratories (Pakistan) was founded in 1948.
Where is Abbott Laboratories (Pakistan) headquartered? Abbott Laboratories (Pakistan) is headquartered in Pakistan.
How many employees does Abbott Laboratories (Pakistan) have? As of today, Abbott Laboratories (Pakistan) has 1.4K+ employees.
Is Abbott Laboratories (Pakistan) publicy listed? Yes, Abbott Laboratories (Pakistan) is a public company listed on KAR.
What is the stock symbol of Abbott Laboratories (Pakistan)? Abbott Laboratories (Pakistan) trades under ABOT ticker.
When did Abbott Laboratories (Pakistan) go public? Abbott Laboratories (Pakistan) went public in 1982.
Who are competitors of Abbott Laboratories (Pakistan)? Similar companies to Abbott Laboratories (Pakistan) include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Abbott Laboratories (Pakistan)? Abbott Laboratories (Pakistan)'s current market cap is $433M
Is Abbott Laboratories (Pakistan) profitable? Yes, Abbott Laboratories (Pakistan) is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.